Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03282838 · ClinicalTrials.gov registry record · Phase 1
Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects
A Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT03282838 is a Phase 1 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 24 participants.
The verdict
NCT03282838, a Phase 1 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
An Open-Label, Three-Way Randomized, Single Dose Crossover Study Comparing Bioavailability of DFN-15 under fasting conditions versus Comparator under fed conditions and to determine food-effect of DFN-15 in Healthy Adult Subjects
Interventions
- DRUG DFN-15 (fasted)
- DRUG DFN-15 (fed)
- DRUG Comparator Celebrex® (fed)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-06-09 |
| Est. Completion | 2018-01-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03282838
The ClinicalTrials.gov registry entry for NCT03282838 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which DFN-15 (fasted) is the first listed.
NCT03282838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03282838 about?
NCT03282838 is a clinical study titled "Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects". An Open-Label, Three-Way Randomized, Single Dose Crossover Study Comparing Bioavailability of DFN-15 under fasting conditions versus Comparator under fed conditions and to determine food-effect of DFN-15 in Healthy Adult Subjects
What is the current status of trial NCT03282838?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2017-06-09. Estimated completion is 2018-01-12.
What interventions are being tested in trial NCT03282838?
The interventions under investigation include: DFN-15 (fasted) (DRUG), DFN-15 (fed) (DRUG), Comparator Celebrex® (fed) (DRUG).
Who is sponsoring clinical trial NCT03282838?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.